Page 120 - 202005

·药师与药学服务·

成都市社会药房慢病管理服务现状调查研究 Δ

王 静 ，张臣宇，吴 迪，胡晓雯，甘 磊，胡 明，周乃彤（四川大学华西药学院，成都 610041）
＊
#
中图分类号 R952 文献标志码 A 文章编号 1001-0408（2020）05-0622-05
DOI 10.6039/j.issn.1001-0408.2020.05.23
摘 要 目的：为社会药房开展慢病管理服务提供参考。方法：设计《成都市社会药房慢病管理服务现状调查问卷》，采用配额抽
样法，于2018年5－7月抽取成都市5个主城区的社会药房（每家药房发放1份问卷），对其基本情况及慢病管理服务开展情况、慢
病管理服务的认知情况、慢病管理服务面临的挑战情况等进行问卷调查并提出改进建议。结果与结论：共发放问卷272份，回收
有效问卷 252 份（有效回收率为 92.65％）。共 189 家（75.00％）社会药房开展了慢病管理服务，其中 112 家（59.26％）开展时间为
1～3年，87家（46.03％）设立了服务专区，68家（35.98％）配备了专职专员，54家（28.57％）配备了兼职人员，且多为执业药师，116
家（61.37％）药房针对相关工作人员的培训次数主要为 1～2 次/年。开展的慢病管理服务项目包括基础指标检测（176 家，
93.12％）、建立健康档案（142家，75.13％）、合理用药指导（163家，86.24％）等；调查认为慢病管理服务的实质性收益包括改变患者
健康状态（163家，86.24％）、提升患者对药房及工作人员的信任度（141家，74.60％）、改善患者生命质量（129家，68.25％）等；50％
以上的药房面临着驻店执业药师数量有限（102家，53.97％）、难以组建专业团队（112家，59.26％）、患者对慢病管理服务缺乏信任
（101家，53.44％）等挑战。成都市社会药房慢病管理服务处于积极探索初期，可为患者及药房带来诸多收益，有利于医疗卫生政
策的推进，但同时存在部分薄弱环节。建议相关政府部门加大政策法规的支持力度；社会药房不断提升自身专业化水平；依托“互
联网+”优势，满足公众多样化的药学服务需求；加大宣传力度，提升慢病患者的认知度和参与度。
关键词 成都；社会药房；慢病管理服务；现状；问题；问卷调查

Investigation and Study on the Current Situation of Chronic Disease Management Service in Social
Pharmacy of Chengdu
WANG Jing，ZHANG Chenyu，WU Di，HU Xiaowen，GAN Lei，HU Ming，ZHOU Naitong（West China School
of Pharmacy，Sichuan University，Chengdu 610041，China）

ABSTRACT OBJECTIVE：To provide reference for chronic disease management service develophed in social pharmacy.
METHODS：Questionnaire about the Status Quo of Chronic Disease Management and Service in Social Pharmacy of Chengdu was
designed，using the quota sampling method，social pharmacies in five main urban areas of Chengdu were selected from May to
July，2018 to conduct a questionnaire survey （one questionnaire by each social pharmacy） on the basic situation of social
pharmacies，the development of chronic disease management services，the cognition of chronic disease management services，and
the challenges faced by chronic disease management services，and suggestions were proposed. RESULTS & CONCLUSIONS：A
total of 272 questionnaires were sent out，and 252 valid questionnaire were actually collected（effective recovery rate of 92.65％）.
Totally 189 sample pharmacies （75.00％） had carried out chronic disease management services，of which 112 （59.26％）
pharmacies had been launched for 1-3 years；87（46.03％）had set up service areas；68（35.98％）had full-time staff，and 54
（28.57％）had part-time staff，most of which were licensed pharmactists. 116（61.37％）had trained related staff for 1-2 times per
year. 176（93.12％）pharmacies could provide services such as basic indicator testing（176，93.12％），establishing health records
（142，75.13.％），and rational medication guidance for patients（163，86.24％）. According to the survey，the substantial benefits
of chronic disease management services included changing the health status of patients（163，86.24％），improving patients’trust
in the pharmacy and staff（141，74.60％），improving patients’quality of life（129，68.25％），etc. More than 50％ of pharmacies
faced the challenges of limited number of licensed pharmacists（102，53.97％），difficulty in establishing professional teams（112，
59.26％），and lack of trust in services（101，53.44％）. The current chronic disease management service of social pharmacy in
Chengdu is in the initial stage of active exploration，which can bring many benefits to patients and pharmacies，and is conducive to
the promotion of medical and health policies，but there are some weak links at the same time. It is suggested that relevant
government departments should strengthen the support of
Δ 基金项目：国家自然科学基金资助项目（No.71473170）
policies and regulations， and social pharmacies constantly
＊硕士研究生。研究方向：药物政策、药物经济学。电话：028-
improve professional level and rely on the advantages of
85501387。 E-mail：2191043137@qq.com
# 通信作者：副教授，硕士。研究方向：医药卫生政策、药物经济 “Internet + ” to meet the diverse needs of the public for
学、药学教育。电话：028-85501387。E-mail：zhou-2316@163.com pharmaceutical care，and publicity efforts are intensified to

·622 · China Pharmacy 2020 Vol. 31 No. 5 中国药房 2020年第31卷第5期